戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y, had both feet, and did not have a current foot infection.
2 ertapenem versus piperacillin/tazobactam for foot infections.
3 IL-8 was seen in 8 of 8 patients with active foot infection and diffuse uptake was seen in the thumb
4 enously into 8 diabetic patients with active foot infections and evidence of osteomyelitis, 2 patient
5 aring, treating lower extremity ischemia and foot infection, and early referral for multidisciplinary
6 ls related to infected hardware and diabetic foot infections, and briefly review standards of treatme
7 r, and treating lower extremity ischemia and foot infection are first-line therapies for diabetic foo
8                                              Foot infections are a common and serious problem in pers
9                                     Diabetic foot infections are a common and serious problem, yet fe
10                                     Diabetic foot infections are a leading cause of lower extremity a
11                                     Diabetic foot infections cause substantial morbidity and mortalit
12  Diseases Society of America (IDSA) diabetic foot infection classification by adding a separate tier
13  trial in adults (n=586) with diabetes and a foot infection classified as moderate-to-severe and requ
14  of bacterial strains isolated from diabetic foot infections (DFI).
15  limb threatening ischemia(CLTI) or diabetic foot infection(DFI).
16                                     Diabetic foot infections (DFIs) typically begin in a wound, most
17 the treatment of moderate-to-severe diabetic foot infections (DFIs), we obtained 454 pretreatment spe
18 ty for Vascular Surgery Wound, Ischemia, and Foot Infection grade 2 wounds were present in 543 patien
19 associated with improved clinical outcome of foot infection in diabetic patients.
20 adjuvant therapy for the treatment of severe foot infections in diabetic patients.
21  absent from invasive isolates from diabetic foot infections, including osteomyelitis.
22  complication, including chronic foot ulcer, foot infection, or foot amputation.
23 the most common infection in the first year, foot infections predominated thereafter.
24 ipidomic adaptations of bacteria in diabetic foot infections, thereby laying the groundwork for futur
25                    40 diabetic patients with foot infections were enrolled in a double-blind placebo-
26 onsidered for parenteral therapy of diabetic foot infections, when deemed appropriate.